Business Daily.
.
A+ R A-

Cytox and Affymetrix Form Strategic Partnership to Develop and Commercialize Blood-Based Genetic Assay for Alzheimer’s Disease Risk Assessment

E-mail Print PDF
OXFORD, England--(BUSINESS WIRE)--Cytox and Affymetrix form strategic partnership to develop and commercialize blood-based genetic assay for Alzheimer’s disease.

imageimage

Read more

Grow Your Business with Times Media
Business Daily Media